Incidence and risk factors for intussusception among children in northern Israel from 1992 to 2009: a retrospective study

BMC Pediatrics

Moshe Ephros²  Dani Cohen¹  Sophy Goren¹  Sigalit Efraim¹  Eias Kassem³  Khitam Muhsen¹ 

[1] Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel;Department of Pediatrics, Carmel Medical Center and the Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel;Department of Pediatrics, Hillel Yaffe Medical Center, Hadera, Israel

关键词: Pediatrics;    Ethnicity;    Surgery;    Risk factors;    Intussusception;   

Others  :  1138433
DOI  :  10.1186/1471-2431-14-218

 received in 2014-02-26, accepted in 2014-07-29,  发布年份 2014

【 摘 要 】

Background

Determining the background incidence of intussusception is important in countries implementing rotavirus immunization. Rotavirus immunization was introduced into the routine infant immunization program in Israel during late 2010. Incidence and risk factors for intussusception were examined in children aged less than five years between 1992 and 2009.

Methods

Data were collected from medical records of children hospitalized due to intussusception (N = 190), and from control children (N = 295), at Carmel and Hillel Yaffe hospitals in northern Israel.

Results

The average annual incidence of intussusception in Jewish and Arab children aged less than five years was estimated at 36.1 (95% CI 17.0-76.5) vs. 23.2 per 100,000 (95% CI 9.3-57.9); for infants less than 12 months of age- 128.1 (95% CI 53.0-309.6) vs. 80.1 (95% CI 29.1-242.6) per 100,000. The risk of intussusception was higher in infants aged 3–5 months: OR 5.30 (95% CI 2.11-13.31) and 6–11 months: OR 2.53 (95% CI 1.13-5.62) when compared to infants aged less than 3 months; in those living in low vs high socioeconomic communities: OR 2.81 (95% CI 1.45-5.43), and in children with recent gastroenteritis: OR 19.90 (95% CI 2.35-168.32) vs children without recent gastroenteritis. Surgical reduction was required in 23.2%. The likelihood of surgery was significantly increased in patients presenting with bloody stool, in Arabs and those who were admitted to Hillel Yaffe Hospital.

Conclusions

The incidence of intussusception prior to universal rotavirus immunization was documented in northern Israel. Despite the lower incidence, Arab patients underwent surgery more often, suggesting delayed hospital admission of Arab as opposed to Jewish patients.

【 授权许可】

   
2014 Muhsen et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Bines J, Ivanoff B: Acute Intussusception in Infants and Children: Incidence, Clinical Presentation and Management: A Global Perspective. Geneva: World Health Organization; 2002.
• [2]Pepper VK, Stanfill AB, Pearl RH: Diagnosis and management of pediatric appendicitis, intussusception, and Meckel diverticulum. Surg Clin North Am 2012, 92:505-526. vii
• [3]Bines JE, Patel M, Parashar U: Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception. J Infect Dis 2009, 200(Suppl 1):S282-S290.
• [4]Huppertz HI, Soriano-Gabarro M, Grimprel E, Franco E, Mezner Z, Desselberger U, Smit Y, Wolleswinkel van den Bosch J, De Vos B, Giaquinto C: Intussusception among young children in Europe. Pediatr Infect Dis J 2006, 25:S22-S29.
• [5]Mandeville K, Chien M, Willyerd FA, Mandell G, Hostetler MA, Bulloch B: Intussusception: clinical presentations and imaging characteristics. Pediatr Emerg Care 2012, 28:842-844.
• [6]Samad L, Marven S, El Bashir H, Sutcliffe AG, Cameron JC, Lynn R, Taylor B: Prospective surveillance study of the management of intussusception in UK and Irish infants. British J Surg 2012, 99:411-415.
• [7]Parashar UD, Holman RC, Cummings KC, Staggs NW, Curns AT, Zimmerman CM, Kaufman SF, Lewis JE, Vugia DJ, Powell KE, Glass RI: Trends in intussusception-associated hospitalizations and deaths among US infants. Pediatrics 2000, 106:1413-1421.
• [8]O’Ryan M, Lucero Y, Pena A, Valenzuela MT: Two year review of intestinal intussusception in six large public hospitals of Santiago, Chile. Pediatr Infect Dis J 2003, 22:717-721.
• [9]Chen YE, Beasley S, Grimwood K, New Zealand Rotavirus Study Group: Intussusception and rotavirus associated hospitalisation in New Zealand. Arch Dis Childhood 2005, 90:1077-1081.
• [10]Greenberg D, Givon-Lavi N, Newman N, Wheeler J, Cohen Z, Dagan R: Intussusception in children in Southern Israel: disparity between 2 populations. Pediatr Infect Dis J 2008, 27:236-240.
• [11]Mansour AM, ElKoutby M, El Barbary MM, Mohamed W, Shehata S, El Mohammady H, Mostafa M, Riddle MS, Sebeny PJ, Young SYN, Abdel-Messih I: Enteric viral infections as potential risk factors for intussusception. J Infect Dev Ctries 2013, 7:28-35.
• [12]Nylund CM, Denson LA, Noel JML: Bacterial enteritis as a risk factor for childhood. Intussusception: a retrospective cohort study (vol 156, pg 761, 2010). J Pediatric 2010, 157:696-696.
• [13]Lappalainen S, Ylitalo S, Arola A, Halkosalo A, Rasanen S, Vesikari T: Simultaneous presence of human herpesvirus 6 and adenovirus infections in intestinal intussusception of young children. Acta Paediatrica 2012, 101:663-670.
• [14]Hsu HY, Kao CL, Huang LM, Ni YH, Lai HS, Lin FY, Chang MH: Viral etiology of intussusception in Taiwanese childhood. Pediatr Infect Dis J 1998, 17:893-898.
• [15]Bines JE, Liem NT, Justice FA, Son TN, Kirkwood CD, De Campo M, Barnett P, Bishop RF, Robins-Browne R, Carlin JB: Risk factors for intussusception in infants in Vietnam and Australia: adenovirus implicated, but not rotavirus. J Pediatric 2006, 149:452-460.
• [16]Velazquez FR, Luna G, Cedillo R, Torres J, Munoz O: Natural rotavirus infection is not associated to intussusception in Mexican children. Pediatr Infect Dis J 2004, 23:S173-S178.
• [17]Chang EJ, Zangwill KM, Lee H, Ward JI: Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines. Pediatr Infect Dis J 2002, 21:97-102.
• [18]Centers for Disease Control and Prevention: Withdrawal of rotavirus vaccine recommendation. JAMA 1999, 282:2113-2114.
• [19]Centers for Disease Control and Prevention: Withdrawal of rotavirus vaccine recommendation. MMWR Morb Mortal Wkly Rep 1999, 48:1007.
• [20]Glass RI, Parashar UD, Bresee JS, Turcios R, Fischer TK, Widdowson MA, Jiang B, Gentsch JR: Rotavirus vaccines: current prospects and future challenges. Lancet 2006, 368:323-332.
• [21]Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM, Rotavirus Efficacy and Safety Trial (REST) Study Team: Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006, 354:23-33.
• [22]Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, Cervantes Y, Linhares AC, López P, Macías-Parra M, Ortega-Barría E, Richardson V, Rivera-Medina DM, Rivera L, Salinas B, Pavía-Ruz N, Salmerón J, Rüttimann R, Tinoco JC, Rubio P, Nuñez E, Guerrero ML, Yarzábal JP, Damaso S, Tornieporth N, Sáez-Llorens X, et al.: Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006, 354:11-22.
• [23]Haber P, Patel M, Izurieta HS, Baggs J, Gargiullo P, Weintraub E, Cortese M, Braun MM, Belongia EA, Miller E, Ball R, Iskander J, Parashar UD, et al.: Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics 2008, 121:1206-1212.
• [24]Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, Hambidge SJ, Glanz JM, Klein NP, Weintraub E: Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA 2012, 307:598-604.
• [25]Buttery JP, Danchin MH, Lee KJ, Carlin JB, McIntyre PB, Elliott EJ, Booy R, Bines JE, Grp PAS: Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine 2011, 29:3061-3066.
• [26]Patel MM, Lopez-Collada VR, Bulhoes MM, De Oliveira LH, Marquez AB, Flannery B, Esparza-Aguilar M, Renoiner EIM, Luna-Cruz ME, Sato HK, Hernández-Hernández Ldel C, Toledo-Cortina G, Cerón-Rodríguez M, Osnaya-Romero N, Martínez-Alcazar M, Aguinaga-Villasenor RG, Plascencia-Hernández A, Fojaco-González F, Hernández-Peredo Rezk G, Gutierrez-Ramírez SF, Dorame-Castillo R, Tinajero-Pizano R, Mercado-Villegas B, Barbosa MR, Maluf EM, Ferreira LB, De Carvalho FM, Dos Santos AR, Cesar ED, De Oliveira ME, et al.: Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. New Eng J Med 2011, 364:2283-2292.
• [27]Velazquez FR, Colindres RE, Grajales C, Hernandez MT, Mercadillo MG, Torres FJ, Cervantes-Apolinar M, DeAntonio-Suarez R, Ortega-Barria E, Blum M, Breuer T, Verstraeten T: Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Pediatr Infect Dis J 2012, 31:736-744.
• [28]Tate JE, Steele AD, Bines JE, Zuber PLF, Parashar UD: Research priorities regarding rotavirus vaccine and intussusception: a meeting summary. Vaccine 2012, 30:A179-A184.
• [29]Rotavirus vaccines. WHO position paper - January 2013 Wkly Epidemiol Rec 2013, 88:49-64.
• [30]Vesikari T, Van Damme P, Giaquinto C, Gray J, Mrukowicz J, Dagan R, Guarino A, Szajewska H, Usonis V, Expert Working Group: European Society for Paediatric Infectious Diseases/European Society for Paediatric Gastroenterology, Hepatology, and Nutrition evidence-based recommendations for rotavirus vaccination in Europe: executive summary. J Pediatr Gastroenterol Nutr 2008, 46:615-618.
• [31]Muhsen K, Shulman L, Rubinstein U, Kasem E, Kremer A, Goren S, Zilberstein I, Chodick G, Ephros M, Cohen D, TAU-HCLV Rota Study Group: Incidence, characteristics, and economic burden of rotavirus gastroenteritis associated with hospitalization of Israeli children <5 years of age, 2007–2008. J Infect Dis 2009, 200(Suppl 1):S254-S263.
• [32]Israel Central Bureau of Statistics: Characterization and Classification of Local Authorities by the Socio-Economic Level of the Population 2001. Jerusalem: Israel; 2004.
• [33]Gay N, Ramsay M, Waight P: Rotavirus vaccination and intussusception. Lancet 1999, 354:956-956.
• [34]Fischer TK, Bihrmann K, Perch M, Koch A, Wohlfahrt J, Kare M, Melbye M: Intussusception in early childhood: a cohort study of 1.7 million children. Pediatrics 2004, 114:782-785.
• [35]Kohl LJ, Streng A, Grote V, Koletzko S, Liese JG: Intussusception-associated hospitalisations in Southern Germany. Eur J Pediatric 2010, 169:1487-1493.
• [36]Tate JE, Simonsen L, Viboud C, Steiner C, Patel MM, Curns AT, Parashar UD: Trends in intussusception hospitalizations among US infants, 1993–2004: Implications for monitoring the safety of the new rotavirus vaccination program. Pediatrics 2008, 121:E1125-E1132.
• [37]Justice F, Carlin J, Bines J: Changing epidemiology of intussusception in Australia. J Paediatr Child Health 2005, 41:475-478.
• [38]Johnson B, Gargiullo P, Murphy TV, Parashar UD, Patel MM: Factors associated with bowel resection among infants with intussusception in the United States. Pediatr Emerg Care 2012, 28:529-532.
• [39]Johnson B, Gargiullo P, Murphy TV, Parashar UD, Patel MM: Sociodemographic and dietary risk factors for natural infant intussusception in the United States. J Pediatr Gastroenterol Nutr 2010, 51:458-463.